Trial intelligence / Profile preview

Inpatient versus outpatient misoprostol for first-trimester abortion induction

IRCT20190128042522N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of misoprostol in abortion (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Success rate of spontaneous abortion and Need for transfusion. Started Feb 2019; status: completed.

02

Drugs

misoprostol
03

Conditions

abortion

Beyond the preview

Go deeper on IRCT20190128042522N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190128042522N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call